Drug Database
Back to search

Poland· PL-100449458

Solacutan

A diclofenac product containing diclofenacum natricum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 9 of our 19 countries.

ATC D11AX18

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSolacutanATCD11AX18REGISTER NO.PL-100449458PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about diclofenacum natricumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diclofenac is registered in 9 of 19 countries.

Countries holding a registration under ATC D11AX18 (diclofenac), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search diclofenac products by name

Diclofenac · ATC D11AX18

9 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Diclofenacum natricum
Manufacturer
Delfarma Sp. z o.o.
Country
Poland (PL)
ATC code
D11AX18
ATC class
Diclofenac
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991450144
  • gtin
    05909991450151

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

131 interactions on record for diclofenac.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check diclofenac against other medicinesHow interaction checks work

Diclofenac · interactions on record

131 records

  • 9 severe
  • 122 moderate

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Diclofenac in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All diclofenac products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Dedolor Akut, Dedolor Drs
  • Belgium · Cataflam, Dicloabak
  • Bulgaria · Diclofenac-Tchaikapharma, Алмирал
  • Cyprus · Almiral, Areston
  • Czechia · Almiral, Dicloabak
  • Germany · Arthrex Schmerzgel, Diclac
  • Denmark · Diclodan, Diclofenac Bluefish
  • Estonia · Almiral, Dagesil
  • Spain · Cinfadol, Dagesil
  • Finland · Dicloabak, Diclomex Rapid
  • France · Antalcalm, Diclamine
  • United Kingdom (Northern Ireland) · Akis, Amgesic Muscle & Back Pain Relief
  • Greece · Batafil, Denaclof
  • Croatia · Diclac Duo, Diclo Duo
  • Hungary · Algoplast, Cataflam
  • Ireland · Cataflam, Diclac
  • Iceland · Diclofenac Alvogen, Dimax
  • Italy · Brexiadvance, Dealgic
  • Lithuania · Dagesil, Diclac
  • Luxembourg · Cataflam, Dicloabak
  • Latvia · Almiral, Dagesil
  • Malta · Almiral, Areston
  • Netherlands · Areston, Dicloabak
  • Norway · Cataflam, Diclofenac Bluefish
  • Portugal · Dagesil, Dicipan
  • Romania · Almiral, Clafen
  • Sweden · Dicloabak, Diclofenac Bluefish
  • Slovenia · Diclo Duo, Dicloflex
  • Slovakia · Akis Plus, Almiral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8846a359-f083-4cc4-a8a5-aa328f0fdc56
GET /v1/drugs/8846a359-f083-4cc4-a8a5-aa328f0fdc56?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Żel",
  "source": "urpl",
  "strength": "30 mg/g",
  "packaging": "05909991450144 ¦ Rp ¦ 139598\n1 tuba 26 g\n05909991450151 ¦ Rp ¦ 139599\n1 tuba 60 g",
  "substance": "Diclofenacum natricum 30 mg/1 g",
  "common_name": "Diclofenacum natricum",
  "pl_product_id": "100449458",
  "pozwolenie_nr": "86/21",
  "auth_procedure": "IR",
  "authorisation_validity": "2026-03-12"
}
API referenceMCP serverPlans

See everything about diclofenac.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console